STING1 and cancer: Recently, the impact of c-GAS-STING pathway activation following the release of cytosolic DNA has been highlighted as central to generating a robust immune reaction in MMRd cancers by activating the type I interferon (IFN-I) response (Fig. 1, orange panel) [19, 39, 40].